Brian S. Bronk

634 total citations
26 papers, 356 citations indexed

About

Brian S. Bronk is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Brian S. Bronk has authored 26 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 10 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Brian S. Bronk's work include Alzheimer's disease research and treatments (6 papers), Chemical Synthesis and Analysis (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Brian S. Bronk is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Chemical Synthesis and Analysis (4 papers) and Synthetic Organic Chemistry Methods (4 papers). Brian S. Bronk collaborates with scholars based in United States and China. Brian S. Bronk's co-authors include John C. Cochran, Stephen J. Lippard, Harmony K. Phillips, Jed L. Hubbs, Nathan O. Fuller, Timothy D. McKee, Barbara Tate, Robyn Loureiro, John D. Protasiewicz and Ruichao Shen and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Organometallics.

In The Last Decade

Brian S. Bronk

26 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian S. Bronk United States	13	167	88	73	66	45	26	356
Regina M. Black United States	10	131 0.8×	197 2.2×	49 0.7×	83 1.3×	13 0.3×	12	412
Elvis A. F. Martis India	10	58 0.3×	141 1.6×	41 0.6×	38 0.6×	30 0.7×	23	415
Robert A. Zambias United States	11	175 1.0×	136 1.5×	19 0.3×	110 1.7×	32 0.7×	15	434
Adriel Villegas‐Estrada United States	6	165 1.0×	156 1.8×	41 0.6×	65 1.0×	9 0.2×	8	465
Gerardo D. Francisco United States	10	189 1.1×	186 2.1×	31 0.4×	61 0.9×	15 0.3×	16	389
M.C. Van Zandt United States	8	215 1.3×	196 2.2×	38 0.5×	43 0.7×	3 0.1×	10	480
Kazuhiko Takatori Japan	14	186 1.1×	183 2.1×	28 0.4×	134 2.0×	8 0.2×	62	544
Héctor Torres‐Gómez Germany	9	181 1.1×	129 1.5×	14 0.2×	17 0.3×	13 0.3×	18	333
Matthew C. O’Reilly United States	11	117 0.7×	217 2.5×	11 0.2×	19 0.3×	29 0.6×	19	351
Laïla El Kihel France	12	114 0.7×	161 1.8×	9 0.1×	32 0.5×	21 0.5×	22	337

Countries citing papers authored by Brian S. Bronk

Since Specialization

Citations

This map shows the geographic impact of Brian S. Bronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian S. Bronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian S. Bronk more than expected).

Fields of papers citing papers by Brian S. Bronk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian S. Bronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian S. Bronk. The network helps show where Brian S. Bronk may publish in the future.

Co-authorship network of co-authors of Brian S. Bronk

This figure shows the co-authorship network connecting the top 25 collaborators of Brian S. Bronk. A scholar is included among the top collaborators of Brian S. Bronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian S. Bronk. Brian S. Bronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2015). Minimization of drug–drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 25(7). 1621–1626. 6 indexed citations

Shen, Ruichao, Nathan O. Fuller, Jed L. Hubbs, et al.. (2014). Multikilogram-Scale Production of Cycloartenol Triterpenoid Glycosides as Synthetic Intermediates for a γ-Secretase Modulator. Organic Process Research & Development. 18(6). 676–682. 3 indexed citations

Fuller, Nathan O., et al.. (2014). Optimization of a Kilogram-Scale Synthesis of a Potent Cycloartenol Triterpenoid-Derived γ-Secretase Modulator. Organic Process Research & Development. 18(6). 683–692. 4 indexed citations

Loureiro, Robyn, Jo Ann Dumin, Timothy D. McKee, et al.. (2013). Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models. Alzheimer s Research & Therapy. 5(2). 19–19. 20 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Steffen P. Creaser, et al.. (2013). SAR investigations on a novel class of gamma-secretase modulators based on a unique scaffold. MedChemComm. 4(3). 569–569. 8 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2012). Optimization of a Natural Product-Based Class of γ-Secretase Modulators. Journal of Medicinal Chemistry. 55(21). 9270–9282. 38 indexed citations

Tate, Barbara, Timothy D. McKee, Robyn Loureiro, et al.. (2012). Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease. International Journal of Alzheimer s Disease. 2012. 1–10. 20 indexed citations

Fuller, Nathan O., Jed L. Hubbs, Steffen P. Creaser, et al.. (2012). Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside. ACS Medicinal Chemistry Letters. 3(11). 908–913. 18 indexed citations

Li, Jin, Brian S. Bronk, John P. Dirlam, et al.. (2007). In vitro and in vivo profile of 5-[(4′-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity. Bioorganic & Medicinal Chemistry Letters. 17(7). 1996–1999. 13 indexed citations

10.

Li, Jin, Peter Bertinato, Hengmiao Cheng, et al.. (2006). Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents. Bioorganic & Medicinal Chemistry Letters. 16(11). 3039–3042. 7 indexed citations

11.

Silvia, Annette M., Michael A. Letavic, Brian S. Bronk, et al.. (2004). In Vitro Microbiological Characterization of a Novel Azalide, Two Triamilides and an Azalide Ketal against Bovine and Porcine Respiratory Pathogens. The Journal of Antibiotics. 57(4). 280–288. 28 indexed citations

12.

Li, Jin, Michael P. Lynch, Subas M. Sakya, et al.. (2004). In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor. Bioorganic & Medicinal Chemistry. 13(5). 1805–1809. 8 indexed citations

13.

Bronk, Brian S., Michael A. Letavic, D. M. George, et al.. (2003). Synthesis, stereochemical assignment and biological activity of a novel series of C-4″ modified aza-Macrolides. Bioorganic & Medicinal Chemistry Letters. 13(12). 1955–1958. 5 indexed citations

14.

Letavic, Michael A., Brian S. Bronk, Jeffrey Casavant, et al.. (2002). Synthesis and Activity of a Novel Class of Tribasic Macrocyclic Antibiotics: The Triamilides. Bioorganic & Medicinal Chemistry Letters. 12(19). 2771–2774. 39 indexed citations

15.

Bronk, Brian S., John D. Protasiewicz, Laura E. Pence, & Stephen J. Lippard. (1996). Reactions of Low-Valent Group V Dicarbonyl Phosphine Complexes with Carbon-Based Electrophiles To Produce Metal Alkyl, Acyl, Carbyne, and Acetylene Complexes.. Organometallics. 15(15). 3470–3470. 6 indexed citations

16.

Bronk, Brian S., John D. Protasiewicz, & Stephen J. Lippard. (1995). Reductive Coupling of Group 5 Dicarbonyls to Disiloxyacetylene Complexes: Ring Formation and Effects of Increasing Steric Demands. Organometallics. 14(3). 1385–1392. 5 indexed citations

17.

Protasiewicz, John D., Brian S. Bronk, Axel Masschelein, & Stephen J. Lippard. (1994). Electrophile-Promoted Carbyne-CO Coupling at a Tantalum Center. Organometallics. 13(4). 1300–1311. 13 indexed citations

18.

Bronk, Brian S., Stephen J. Lippard, & Rick Danheiser. (1993). Intramolecular conjugate addition reactions via organozinc compounds. Organometallics. 12(8). 3340–3349. 21 indexed citations

19.

Cochran, John C., et al.. (1990). Palladium(0) catalysis in hydrostannation of carbon-carbon triple bonds. Tetrahedron Letters. 31(46). 6621–6624. 46 indexed citations

20.

Cochran, John C., et al.. (1989). Protodestannylation of carbomethoxy-substituted vinylstannanes: Kinetics, stereochemistry and mechanisms. Organometallics. 8(3). 804–812. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact